Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma × Anesthesia, Spinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urinary Bladder Neoplasms 4 Neoplasms 2 Recurrence 1 Postoperative Cognitive Complications 1 Pain, Postoperative 1 Obturator Nerve Block 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplastic Cells, Circulating 1 Myofibroma 1 Melanoma 1 Leiomyoma 1 Inflammatory Bowel Diseases 1 Diverticulitis 1 Colonic Neoplasms 1 Cancer Surgery 1 Agnosia 1

Interventions

pembrolizumab 259 Nivolumab 235 Ipilimumab 214 aldesleukin 121 Cyclophosphamide 121 Interleukin-2 91 trametinib 75 dabrafenib 67 Dacarbazine 63 fludarabine 62 Vemurafenib 61 Temozolomide 59 fludarabine phosphate 55 Radiosurgery 43 Biopsy 43 Bevacizumab 40 sargramostim 39 incomplete Freund's adjuvant 35 binimetinib 34 Paclitaxel 34 atezolizumab 32 Radiotherapy 32 Magnetic Resonance Spectroscopy 32 Cisplatin 32 Specimen Handling 31 Introns 30 Blood Specimen Collection 30 cobimetinib 29 Carboplatin 29 encorafenib 28

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01588847 2014-12-11

Anesthesia and Cancer Recurrence im Malignant Melanoma

University Hospital Muenster

Phase NA Unknown

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡